Autoantibodies against AT1-Receptor and .ALPHA.1-Adrenergic Receptor in Patients with Hypertension.
スポンサーリンク
概要
- 論文の詳細を見る
<B>This study will explore the autoantibodies against AT<SUB>1</SUB>-receptor and α<SUB>1</SUB>-adrenergic receptor in patients with hypertension. Forty normotensives and 194 patients with hypertension were recruited for participation in this study. All patients accepted systemic combination drug treatment for antihypertension. According to the treatment results and the definition of refractory hypertension, the patients were divided into two groups: a refractory hypertension group and a non-refractory hypertension group. The epitope of the 2nd extracellular loop of type 1 angiotensin (AT<SUB>1</SUB>) receptor and α<SUB>1</SUB>-adrenergic receptor were synthesized and used as antigens to screen the autoantibodies against AT<SUB>1</SUB>-receptor and α<SUB>1</SUB>-adrenergic receptor by ELISA. The plasma renin activity and concentration of angiotensin II and catecholamine were also examined. The positive rates of the autoantibodies against AT<SUB>1</SUB>-receptor and α<SUB>1</SUB>-adrenergic receptor in patients with hypertension, 26.8% (52/194) and 25.3% (49/194), respectively, were higher than those in normotensives (7.5% and 5%)(<I>p</I><0.01). Further investigation showed that the frequencies of the autoantibodies against AT<SUB>1</SUB>-receptor and α<SUB>1</SUB>-adrenergic receptor in patients with refractory hypertension, 42.9% (42/98) and 36.7% (36/98), respectively, were higher than those in patients with non-refractory hypertension under systematic treatment (10.4% and 13.5%)(<I>p</I><0.01). The levels of circulating angiotensin II, catecholamine, proteinuria and serum creatine were also higher in the refractory hypertension group than in the non-refractory hypertension group. The findings showed that the frequencies of autoantibodies against AT<SUB>1</SUB>-receptor and α<SUB>1</SUB>-adrenergic receptor were higher in patients with hypertension, particularly in those with refractory hypertension, and that these autoantibodies might play a role in the pathogenesis of hypertension. (<I>Hypertens Res</I> 2002; 25: 641-646)</B>
- 日本高血圧学会の論文
日本高血圧学会 | 論文
- Telmisartan treatment decreases Visceral Fat Accumulation and improves Serum Levels of Adiponectin and Vascular Inflammation Markers in Japanese Hypertensive Patients.
- The Effects of Verapamil SR and Bisoprolol on Reducing the Sympathetic Nervous System's Activity.
- The Role of Renal Dopamine in the Reduction of High Blood Pressure by β1-Selective β-Blocker with Intrinsic Sympathomimetic Activity in Spontaneously Hypertensive Rats
- Effects of Long-Term Antihypertensive Therapy on Physical Fitness of Men with Mild Hypertension.
- Prediction of Progression of Left Ventricular Hypertrophy in Mild Hypertension: 5-Year Observations without Pharmacological Intervention.